Multi-Source Medication Aggregation
Pulling lists from the record, external prescribing histories, dispensing data, and patient report, retaining each source separately rather than merging into a single list.
AI medication reconciliation engineers build systems that compare medication lists across sources and surface discrepancies for clinical resolution. They handle sig parsing, drug normalization, source provenance, and discrepancy classification, working so a pharmacist or prescriber resolves every difference rather than the system silently merging lists.
Reconciliation is where medication errors concentrate, and the reason is structural: a patient’s medications exist in several places that never agree. The hospital list, the pharmacy fill history, the specialist’s record, and what the patient actually takes are four different answers. Software can surface the differences reliably; it cannot decide which is correct. Taction Software builds to that line, and our hire dedicated developers hub covers adjacent roles.

Our experts are ready to understand your business goals.






























































The work is aggregation, normalization, and difference detection with a clinical resolution workflow on top. Getting to a comparable representation is most of the effort, since the same drug appears with different names, strengths, and instruction formats across sources. The work below reflects that. Resolution workflow appears prominently because surfacing fifty discrepancies without prioritization produces the same outcome as surfacing none.
Pulling lists from the record, external prescribing histories, dispensing data, and patient report, retaining each source separately rather than merging into a single list.
Mapping brand and generic names, strengths, and forms to a common representation so the same medication from different sources is recognized as the same medication.
Interpreting instruction text into structured dose, route, and frequency, since discrepancies frequently exist in instructions rather than in which drug appears.
Categorizing differences by type and clinical significance so a pharmacist reviews consequential discrepancies rather than working through an undifferentiated list.
Collecting what the patient actually takes, including over-the-counter and supplement use, which is frequently the source that disagrees most with the record.
Recording which source was accepted, by whom, and why, since reconciliation decisions are reviewed after adverse events and must be reconstructable.
Reconciliation looks like a data matching problem and is a clinical judgment problem. Deciding whether a discrepancy means the patient stopped a medication, was told to stop, or simply did not fill it requires information the data does not contain. Systems that resolve differences algorithmically will confidently produce wrong lists. The context below spans the healthcare work you assign.
A missing medication may indicate discontinuation, non-adherence, an unfilled prescription, or an incomplete source. Distinguishing these requires clinical inquiry, not data logic.
Dispensing data shows what was collected, not what was taken. Treating fill records as the current regimen produces lists that misrepresent actual medication use.
Same drug, different dose or frequency is a more consequential discrepancy than a missing entry, and instruction text is where normalization is hardest.
Patients are the only source for over-the-counter use and actual adherence, and they also misremember. Their input is necessary and requires verification rather than substitution.
Admission, transfer, and discharge are where medication errors cluster. Reconciliation capability delivers most value if timed to those events rather than run generally.
Systems surface and organize. Deciding what the patient should be taking is a clinical determination made and documented by a qualified professional.
This work is terminology, text parsing, and workflow engineering. Drug normalization and sig parsing are the specialist skills, and both have well-defined resources that engineers should use rather than reimplement. The competencies below reflect that. Weight normalization accuracy and provenance retention above discrepancy logic, since differences detected from poorly normalized data are mostly false.
Working with established medication terminology resources for name, strength, and form mapping, including handling of combination products and formulation differences.
Converting instruction text into dose, route, frequency, and duration with confidence handling, since ambiguous instructions must route to a person rather than being guessed.
Retrieving medication data from record systems, external prescribing histories, and dispensing sources. Our healthcare integration work covers this connectivity.
Keeping each source distinct with its retrieval time, so a reviewer sees where every entry came from rather than a merged list of uncertain origin.
Categorizing differences by type and clinical significance, with prioritization tuned so pharmacist review time concentrates on consequential items.
Recording decisions with actor, reasoning, and source selected, producing the documentation reconciliation review and incident investigation require.
The distinguishing question is whether their system ever merged lists automatically. Engineers who preserved sources and surfaced differences understood the boundary; those who produced a single reconciled list built something clinically unsafe. Our assessment centers on normalization accuracy, provenance, and prioritization judgment. Our delivery process includes review points for reassessing fit.
We ask whether their system produced a single list. Automatic reconciliation makes clinical determinations from data that cannot support them.
We ask how they validated drug matching. Unmeasured normalization produces false discrepancies that consume pharmacist time and erode confidence in the system.
We ask what happened with ambiguous instructions. Systems guessing at unclear sigs create discrepancies that do not exist or hide ones that do.
We ask how they limited review volume. Undifferentiated discrepancy lists get skimmed, which means consequential differences are missed alongside trivial ones.
We ask how reviewers saw source origin. Merged views without provenance prevent the reviewer from weighting sources by their reliability.
We describe which reconciliation systems each engineer built and what pharmacists used. We do not claim pharmacy credentials for engineers who lack them.
Engagements should start with aggregation and normalization at a single transition point rather than with comprehensive reconciliation, because getting sources into comparable form is the substantial work and one transition demonstrates whether it functions. Structures below reflect that. We also confirm pharmacist capacity, since discrepancies surfaced without review capacity produce documented risk and no resolution.
Building multi-source retrieval with reliable drug matching. Without accurate normalization, every subsequent discrepancy detection produces mostly false differences.
Focusing on admission or discharge demonstrates value where medication risk concentrates, and limits scope while normalization accuracy is established.
Discrepancy significance is pharmacy expertise. Engagements pairing engineering with pharmacy produce prioritization that reflects clinical consequence rather than data difference.
Where you own reconciliation workflow, staff augmentation adds engineering capacity working within your existing terminology and documentation standards.
A dedicated healthcare development team suits programs spanning aggregation, normalization, discrepancy detection, resolution workflow, and record integration.
Where the requirement is multi-source retrieval and normalization rather than full reconciliation workflow, a fixed-scope build under our engagement models delivers it.
Share your record system, external prescribing history access, dispensing data, and pharmacist capacity. Source availability determines what reconciliation can compare.
Medication lists drive prescribing, which makes automatic modification unacceptable regardless of confidence. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified. Where intended use may create diagnostic or treatment claims, SaMD classification is assessed during discovery. Pharmacists and prescribers determine what a patient should be taking.
The system never updates the medication list. It surfaces differences for a qualified professional to resolve, since a wrong automatic reconciliation propagates into prescribing.
Each source remains visible with its origin and retrieval time, so a reviewer weights the record, fill history, and patient report according to their reliability.
Unclear instructions and uncertain matches route to a person rather than being interpreted, since a confident guess about a dose is a medication error waiting to occur.
Every resolution records who decided, which source was accepted, and any reasoning captured, because reconciliation is examined closely after adverse medication events.
Psychiatric, substance use treatment, and reproductive medications carry disclosure sensitivity. We built CHIPSS, a behavioral health system, where such segmentation governed access.
We would not build systems that reconcile lists automatically, discontinue medications without clinician action, infer adherence from fill data, or update prescribing records without review.
Cost concentrates in source integration and normalization rather than discrepancy logic. External prescribing history and dispensing data access frequently involve agreements and technical work that set the timeline. We publish no figures on discrepancy detection or medication error reduction, because those depend on your sources, population, and current process. What we deliver is instrumentation for measuring your own results.
$40,000 to $80,000
Multi-source aggregation with drug normalization, sig parsing, discrepancy detection, and pharmacist resolution workflow at one transition point.
$80,000 to $200,000
Reconciliation across transition points with additional sources, patient-reported capture, prioritized discrepancy classification, resolution documentation, and record integration.
Starting at $200,000
Multi-facility deployment across settings and record systems with governance documentation and integration into several clinical environments.
Discovery is paid and time-boxed. It produces a source availability assessment, normalization feasibility review, pharmacist capacity analysis, workflow design, and an itemized fixed-scope estimate.
Source count and access arrangements, normalization scope including combination products, sig parsing complexity, transition points covered, patient-reported capture, and pharmacist workflow integration.
Terminology updates and source changes require maintenance. Budget for normalization accuracy monitoring, sig parsing revalidation, source integration upkeep, and discrepancy volume review.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Two questions matter. Whether the vendor preserves sources rather than merging them, and whether they will confirm pharmacist capacity before surfacing discrepancies. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age. Our wider case for Taction sits elsewhere.
We built Voyant Health, an EHR platform. Our healthcare case studies reflect experience modeling medication data with the provenance reconciliation requires.
We built CHIPSS, a behavioral health system, where psychiatric medication visibility required deliberate segmentation beyond ordinary access control.
We built Revive Ease and PainKare, both FDA-registered applications. That work informs how we document intended use where systems touch medication information.
Taction Software holds ISO 27001 certification covering our information security management practices. It certifies our internal processes and does not determine your organization’s compliance position.
Where clients want a single reconciled list produced by the system, we decline. Determining what a patient should be taking is a clinical judgment that data cannot make.
Discrepancies surfaced without pharmacist capacity to resolve them create documented risk and no improvement. We raise that before scoping detection work.
We review your available sources, transition points, pharmacist capacity, and current workflow, then present matched candidates. You interview and approve each engineer before placement.
Single transition point runs $40,000 to $80,000, cross-setting capability $80,000 to $200,000, and multi-facility deployment starts at $200,000. Terminology licensing and data access are itemized separately.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
No. It preserves each source distinctly and surfaces differences for pharmacist or prescriber resolution, because deciding what a patient should be taking requires clinical inquiry the data cannot supply.
Ambiguous sigs route to a person rather than being interpreted, since a confident guess about dose or frequency introduces a medication error that looks like structured data.
CDS surfaces guidance at ordering based on rules. Reconciliation aggregates and compares medication lists across sources, where normalization and provenance dominate the engineering.
Share your record system, external prescribing history and dispensing access, transition points, pharmacist capacity, sensitive medication requirements, and the engagement model you have in mind. We will confirm source availability and review capacity before scoping detection. We do not promise instant matching or any error reduction figure.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.